DigiHealth Technologies to acquire Pharmarack Technologies
- Country:
- India
DigiHealth Technologies LLP, a wholly-owned entity of ABCD Technologies LLP, will acquire 100 per cent stake in Pharmarack Technologies Pvt Ltd in tranches, according to regulatory filings.
Pharmarack operates a digital platform aimed at integrating and solving problems across the pharmaceutical supply chain.
Drug firms Sun Pharma, Lupin and Alkem Laboratories in separate filings stated that their investee entity ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), has agreed to acquire 100 per cent ownership interest in Pharmarack Technologies Private Limited in tranches.
The acquisition is a step by ABCD Technologies LLP to facilitate, enable and promote efficiency and good distribution practices including digitising healthcare infrastructure in India, inter alia, in support of the National Digital Health Mission of Government of India, they added.
''The upfront acquisition of 91.8 per cent of shareholding in Pharmarack is expected to be completed within a period of 30 days by purchase of shares from multiple existing shareholders in various lots, the filings said.
The remaining 8.2 per cent of the shareholding in Pharmarack is likely to be acquired in multiple tranches over the next five years, it added.
''Cost of acquisition to DigiHealth Technologies LLP for upfront acquisition of 91.8 percent is Rs 111 crore. Cost of acquisition of remaining shareholding shall be linked to future performance of Pharmarack,'' the filings said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Tamil Nadu: The Pillar of Indian Civilization
India's Reform Express: Driving Transformation with Science and Technology
Ambani's Vision: Fueling India's AI Future and Supporting Education
India's Strategic Push for Critical Mineral Security
Infrastructure Hurdles: India's Drive to Resolve Land Acquisition Challenges

